Adolescent and Young Adult Cancer Survival. Issue 49 (19th November 2014)

• Record Type: Journal Article
• Authors: Lewis, Denise Riedel; Seibel, Nita L.; Smith, Ashley Wilder; Stedman, Margaret R.
• Is Part Of: Journal of the National Cancer Institute. Issue 49(2014)
• Page Start: 228
• Page End: 235
• Publication Date: 2014-11-19
• Subjects: Cancer -- Periodicals; Cancer -- Congresses; 616.994
• DOI: 10.1093/jncimonographs/lgu019
• Languages: English
• ISSNs: 1052-6773

Abstract

Abstract: Adolescent and young adults (AYAs) face challenges in having their cancers recognized, diagnosed, treated, and monitored. Monitoring AYA cancer survival is of interest because of the lack of improvement in outcome previously documented for these patients as compared with younger and older patient outcomes. AYA patients 15–39 years old, diagnosed during 2000–2008 with malignant cancers were selected from the SEER 17 registries data. Selected cancers were analyzed for incidence and five-year relative survival by histology, stage, and receptor subtypes. Hazard ratios were estimated for cancer death risk among younger and older ages relative to the AYA group. AYA survival was worse for female breast cancer (regardless of estrogen receptor status), acute lymphoid leukemia (ALL), and acute myeloid leukemia (AML). AYA survival for AML was lowest for a subtype associated with a mutation of the nucleophosmin 1 gene (NPM1). AYA survival for breast cancer and leukemia remain poor as compared with younger and older survivors. Research is needed to address disparities and improve survival in this age group.